Lack of efficacy of carbamazepine in the treatment of panic disorder.
The authors conducted a controlled study of carbamazepine in the treatment of 14 patients with panic disorder. Although there was a statistically significant reduction in symptoms of anxiety on several measures, only one of the patients was judged to have a marked and sustained clinical improvement while taking carbamazepine. Forty percent of the patients had a decrease in frequency of panic attacks during carbamazepine treatment, 50% had an increase, and 10% showed no change. The presence of either EEG abnormalities or prominent psychosensory symptoms did not predict response to carbamazepine. These findings are discussed within the context of an epileptiform model for panic disorder.
D000328:Adult; D000379:Agoraphobia / Q000188:drug therapy / Q000523:psychology; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D002220:Carbamazepine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005239:Fear; D005260:Female; D006801:Humans; D008297:Male; D010200:Panic; D011569:Psychiatric Status Rating Scales
D002220:Carbamazepine